AXICABTAGENE CILOLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN BRAZIL: THE IMPACT OF CAR T-CELL THERAPY WAIT TIME AND TREATMENT SEQUENCING

EHA Library, João De Holanda Farias, 4210270

INDEPENDENT VALIDATION OF THE INTERNATIONAL METABOLIC PROGNOSTIC INDEX (IMPI) ON EFFICACY AND SAFETY OF CAR-T IN PATIENTS WITH AGGRESSIVE LARGE B-CELL LYMPHOMA

EHA Library, Eugenio Galli, 4210271

EARLY LONGITUDINAL HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHANGES WITH TAFASITAMAB–LENALIDOMIDE IN TRANSPLANT-INELIGIBLE RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL): INTERIM PRO-MIND

EHA Library, Alice Di Rocco, 4210272

PRE-TREATMENT ANTIBIOTIC EXPOSURE AND OUTCOMES AFTER BISPECIFIC ANTIBODY THERAPY IN B-CELL NON-HODGKIN LYMPHOMA: A SINGLE-CENTRE RETROSPECTIVE STUDY

EHA Library, Ana Cuervo Fonseca, 4210273

OBSERVATIONS OF CAR T AND CARNEG BYSTANDER T CELL DYNAMICS FOLLOWING EPCORITAMAB TREATMENT IN R/R DLBCL

EHA Library, Kensuke Yanashima, 4210274

REAL-WORLD EXPERIENCE WITH POLATUZUMAB-R-BASED REGIMENS IN PREVIOUSLY UNTREATED LARGE B-CELL LYMPHOMA: A STUDY BY THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES (KROHEM)

EHA Library, Dino Dujmović, 4210275

DIFFUSION MRI–DERIVED QUANTITATIVE METRICS IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Martine Nørskov, 4210276

INCIDENCE AND IMPACT OF MISDIAGNOSIS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): AN ANALYSIS FROM LYMPHOMA COALITION'S 2024 GLOBAL PATIENT SURVEY ON LYMPHOMAS & CLL

EHA Library, Lorna Warwick, 4210277

A MACHINE LEARNING-ASSISTED PROGNOSTIC MODEL FOR PREDICTING OUTCOMES IN B-CELL LYMPHOMA PATIENTS WITH CONCOMITANT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CONSTRUCTION AND INTERNAL VALIDATION

EHA Library, Luocheng Zhang, 4210278

EFFICACY AND SAFETY OF THE POLATUZUMAB, ACALABRUTINIB, RITUXIMAB, AND LENALIDOMIDE (POLA-AR2) REGIMEN AS FIRST-LINE THERAPY IN UNFIT OR FRAIL PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Haiwen Huang, 4210279

REAL-WORLD EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN-BASED REGIMENS IN TREATMENT-NAIVE DLBCL: A MULTICENTER STUDY FOCUSING ON BULKY DISEASE AND CD5 POSITIVITY

EHA Library, Shu zhao, 4210280

REAL-WORLD OUTCOMES OF TAFA-LEN (TAFASITAMAB,LENALIDOMIDE) IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: INSIGHTS FROM THE POLISH LYMPHOMA RESEARCH GROUP (PLRG)

EHA Library, Magdalena Olszewska-Szopa, 4210281

THE ROLE OF POLYMORPHISMS IN THE MYD88 AND CXCR4 GENES IN THE ETIOPATHOGENESIS OF THE DISEASE AND THEIR ASSOCIATIONS WITH PROGNOSIS IN PATIENTS WITH HODGKIN LYMPHOMA OR NON-HODGKIN LYMPHOMA

EHA Library, HANDAN HAYDAROGLU SAHIN, 4210282

EFFICACY AND SAFETY OF EFBEMALENOGRASTIM ALFA IN THE TREATMENT OF NEUTROPENIA INDUCED BY R-CHOP-LIKE REGIMENS IN NEWLY DIAGNOSED NON-HODGKIN'S LYMPHOMA PATIENTS CLINICAL STUDY

EHA Library, Donglu Zhao, 4210283

OUTCOME OF RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA ADMINISTERED WITH CAR T-CELL ALONE OR IN COMBINATION WITH ASCT: A PROPENSITY SCORE MATCHING COHORT STUDY

EHA Library, Fan Yang, 4210284

A SYSTEMATIC ASSESSMENT OF DLBCL CELL-OF-ORIGIN CLASSIFICATION PERFORMANCE EVALUATING NON-INFERIORITY OF HANS IHC TO GEP

EHA Library, Ash Alizadeh, 4210285

PHASE 1 STUDY OF ARV-393, A PROTAC BCL6 DEGRADER, AS MONOTHERAPY IN PATIENTS WITH ADVANCED NON-HODGKIN LYMPHOMA (NHL) OR COMBINED WITH GLOFITAMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Sarit Assouline, 4210286

CD5-POSITIVITY DOES NOT WORSEN OUTCOMES IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMAS TREATED WITH CAR-T CELLS: UPDATED RESULTS FROM THE MULTICENTER PROSPECTIVE CAR-T SIE STUDY

EHA Library, Martina Pennisi, 4210287

ZRTD, A CHEMO-LIGHT REGIMEN, CONFERS FAVORABLE EFFICACY AND SAFETY IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Zheng Ge, 4210289

MOLECULAR FEATURES AND PROGNOSIS OF PRIMARY BONE DIFFUSE LARGE B-CELL LYMPHOMA VERSUS SECONDARY BONE DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Li Bao, 4210291

ASSESSING PROGRESSION-FREE SURVIVAL (PFS) DURABILITY MILESTONES IN INTERIM PRO-MIND RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) TREATED WITH TAFASITAMAB–LENALIDOMIDE

EHA Library, Enrico Derenzini, 4210292

ORELABRUTINIB MAINTENANCE FOR DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS RESPONDING TO R-CHOP

EHA Library, Yi Zhao, 4210293

TRANSFERRIN AS AN EARLY OUTCOME PREDICTOR IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RECEIVING POLATUZUMAB VEDOTIN IN COMBINATION WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE

EHA Library, Ziyang Shi, 4210294

REAL-WORLD OUTCOMES OF PRIMARY CNS LYMPHOMA: A MULTICENTER ANALYSIS FROM EASTERN EUROPEAN AND CENTRAL ASIAN COHORTS

EHA Library, Anastasiia Maliar, 4210295

CLINICAL FEATURES AND OUTCOMES OF METHOTREXATE ASSOCIATED DLBCL- AUSTRALIAN STUDY

EHA Library, Vibooshini Ganeshalingam, 4210296

COMPARISON OF EFFICACY BETWEEN POLA-R-CHP AND TUCIDINOSTAT-R-CHOP IN PREVIOUSLY UNTREATED PATIENTS WITH DOUBLE-EXPRESSOR DIFFUSE LARGE B-CELL LYMPHOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)

EHA Library, Yuqin Song, 4210297

IMPACT OF PRIOR COVALENT BTK INHIBITOR EXPOSURE ON SURVIVAL AFTER RICHTER TRANSFORMATION IN PATIENTS WITH CLL

EHA Library, Truman Koh, 4210298

BASELINE SPLEEN VOLUME IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL AFTER CD19-DIRECTED CAR T-CELL THERAPY IN R/R DLBCL

EHA Library, Lucas Brehm, 4210299

EFFICACY AND SAFETY OF BISPECIFIC ANTIBODIES IN RELAPSED OR REFRACTORY POST TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS : A RETROSPECTIVE COHORT STUDY FROM THE FRENCH REGISTRY KVIROGREF.

EHA Library, Marine Baron, 4210300

FRONTLINE POLATUZUMAB-BASED THERAPY IN  HIGH-RISK DLBCL: REAL-WORLD OUTCOMES AND EXPLORATORY ANALYSIS OF CUMULATIVE RISK BURDEN

EHA Library, Qing Zhang, 4210301

GLOFITAMAB IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA: A COMPARATIVE ANALYSIS WITH HISTORICAL CONTROLS

EHA Library, Jingrui Sui, 4210302

ODRONEXTAMAB FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA BEFORE AUTOLOGOUS CHIMERIC ANTIGEN RECEPTOR T CELL (CART) THERAPIES

EHA Library, Mengyang Di, 4210303

POLATUZUMAB VEDOTIN BASED REGIMENS AS FIRST-LINE THERAPY FOR LARGE B-CELL LYMPHOMA: REAL-WORLD DATA FROM CLINICAL PRACTICE IN THE RUSSIAN FEDERATION

EHA Library, Gayane Tumyan, 4210304

REAL-WORLD OUTCOMES OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL AFTER ≥3 PRIOR LINES OF TREATMENT

EHA Library, Rui Liu, 4210305

COMPARATIVE EFFICACY AND SAFETY OF CD19-DIRECTED THERAPIES IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Hao Yao, 4210306

EDUCATIONAL OUTCOMES OF LIVE AND ENDURING CME/CE FOR HEMATOLOGY/ONCOLOGY CARE TEAMS MANAGING LYMPHOMAS WITH BISPECIFIC ANTIBODIES VIA PRE-/POST- ASSESSMENT

EHA Library, Sarah Elizabeth Bomba, 4210307

A NOVEL PROGNOSTIC INDEX MODEL INCLUDE IL-6 PREDICTS THE CLINICAL OUTCOMES FOR NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, JUN TAO, 4210308

RED CELL DISTRIBUTION WIDTH, SERUM ALBUMIN, AND LACTATE DEHYDROGENASE AS A COMPOSITE PROGNOSTIC SCORE (RAL) IN DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE COHORT STUDY

EHA Library, Dragana Grohovac, 4210309

NOVEL CLGAB VS BEAM-L CONDITIONING IN HIGH-RISK LYMPHOMA ASCT: A PROSPECTIVE STUDY ON LONG-TERM OUTCOMES

EHA Library, Xiangli Chen, 4210310

FRONTLINE POLA-BASED THERAPY IN NEWLY DIAGNOSED DLBCL WITH HIGH-RISK EXTRANODAL INVOLVEMENT FOR CNS RELAPSE: A REAL-WORLD STUDY

EHA Library, Fenghua Gao, 4210311

COMPARISON OF ORELABRUTINIB, RITUXIMAB, AND METHOTREXATE (OR-MTX) VERSUS RITUXIMAB AND METHOTREXATE (R-MTX) IN FIRST-LINE TREATMENT OF PRIMARY CNS LYMPHOMA: A RETROSPECTIVE ANALYSIS

EHA Library, Fang shu Guan, 4210313

GLOFITAMAB DEMONSTRATES SUPERIOR EFFICACY COMPARED WITH SECOND-DIFFERENT-TARGET CAR-T AS SALVAGE THERAPY AFTER CD19 CAR-T FAILURE IN R/R B-CELL NON-HODGKIN LYMPHOMA

EHA Library, lixia ma, 4210314

EPCOREAL: A PROSPECTIVE OBSERVATIONAL TRIAL-IN-PROGRESS OF EPCORITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA

EHA Library, Christian Buske, 4210316

GLOFITAMAB IN CNS LYMPHOMA: VERSATILITY FOR RECURRENT AND TREATMENT-NAÏVE DISEASE.

EHA Library, Daria Koroleva, 4210317

DELAYED T-CELL ACTIVATION AND STAGE-SPECIFIC IMMUNE REPROGRAMMING AFTER CRYOABLATION IN HEMATOLOGIC MALIGNANCIES: INSIGHTS FROM SINGLE-CELL SEQUENCING AND ANIMAL MODELS

EHA Library, Xing Cui, 4210318

TNFRSF14 MUTATIONS ARE ASSOCIATED WITH INCREASED RELAPSE RISK AND POOR SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Xia Zhao, 4210319

A PROSPECTIVE, SINGLE-ARM, PHASE Ⅱ TRIAL OF THIOTEPA, PIRTOBRUTINIB AND SINTILIMAB (TPP) IN PATIENTS WITH UNFIT OR RELAPSED/REFRACTORY PRIMARY OR SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Li Cong, 4210320

THE SOMATIC MUTATION PROFILE OF RUSSIAN PATIENTS WITH DLBCL: PRELIMINARY NGS FINDINGS FROM A SINGLE-CENTER STUDY

EHA Library, Evgeniy Zvonkov, 4210321

PROGNOSTIC IMPACT OF PRE-TRANSPLANT DISEASE STATUS AND DEAUVILLE SCORE ON OUTCOME AFTER AUTOLOGOUS STEM CELL TRANSPLANT IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Pei Shin Teo, 4210323

REAL-WORLD OUTCOMES OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA IN THE ERA OF NOVEL AGENTS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Xue Yang, 4210324

CLINICAL AND ECONOMIC OUTCOMES BY RISK GROUP AMONG FIRST-LINE PATIENTS WITH LARGE B-CELL LYMPHOMA IN THE UNITED STATES-SEER-MEDICARE DATA ANALYSIS

EHA Library, Yi Lin, 4210325

THE OUTCOME OF CAR-T THERAPY FOR CENTRAL NERVOUS SYSTEM LYMPHOMA FOLLOWING FAILED AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Rui Liu, 4210326

A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY OF UB-VV400 IN COMBINATION WITH RAPAMYCIN IN RELAPSED OR REFRACTORY B-CELL MALIGNANCIES

EHA Library, Jacob Garcia, 4210327

EFFICACY ANALYSIS OF A FOUR-DRUG REGIMEN IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Shaojie Wu, 4210328

PERIPHERAL T‑CELL IMMUNOPHENOTYPING UNDER EPCORITAMAB EXPOSURE IN AGGRESSIVE B‑CELL LYMPHOMAS: A MULTICENTER REAL‑WORLD STUDY

EHA Library, Francesco GAUDIO, 4210329

WHAT DRIVES EARLY MORTALITY IN PATIENTS OVER 75 WITH DIFFUSE LARGE B-CELL LYMPHOMA?

EHA Library, Mónica Fernández, 4210330

LABORATORY-IPI (LAB-IPI) IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A HELLENIC DATABASE VALIDATION

EHA Library, Theodoros Vassilakopoulos, 4210332

FIRST-LINE PRIMZ-D CHEMOIMMUNOTHERAPY FOR PRIMARY CNS LYMPHOMA: REAL-WORLD EFFICACY IN A SINGLE-CENTER COHORT

EHA Library, Honghui Huang, 4210333

REAL-WORLD OUTCOMES AND HEALTHCARE DISPARITIES IN DIFFUSE LARGE B-CELL LYMPHOMA: A 7-YEAR RETROSPECTIVE COHORT STUDY IN A BRAZILIAN PUBLIC UNIVERSITY HOSPITAL

EHA Library, Carolina Ribeiro de Castro Pires, 4210334

VALUE OF THE IL-1Β/IL-10 RATIO IN PREDICTING RESPONSE TO R-CHOP THERAPY IN PATIENTS WITH DLBCL

EHA Library, Lijuan Li, 4210335

LATE-ONSET NEUTROPENIA AND HYPOGAMMAGLOBULINEMIA IN DLBCL PATIENTS TREATED WITH THE R-DA-EPOCH REGIMEN

EHA Library, Marko Lucijanic, 4210336

REAL WORLD DATA ON CD20CD3 BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA –KROHEM

EHA Library, Barbara Dreta, 4210337

EACH DAY OF TREATMENT DELAY AFTER DIAGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA INCREASES THE HAZARD OF DEATH BY 1.5%: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Vojin Vukovic, 4210338

OUTCOMES AND OPTIMAL SEQUENCING OF SALVAGE THERAPIES FOLLOWING CD19-DIRECTED CAR-T FAILURE IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: A SINGLE-CENTER REAL-WORLD ANALYSIS

EHA Library, Liang Wang, 4210339

COMPARISON OF THE EFFICACY OF ZANUBRUTINIB PLUS RITUXIMAB-BASED REGIMEN AS FIRST-LINE TREATMENT IN PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Zheng Ge, 4210340

TREATMENT OUTCOMES FOR PATIENTS WITH PRIMARY CNS LYMPHOMA. DATA FROM A SINGLE-CENTER STUDY

EHA Library, Daria Koroleva, 4210341

UPFRONT POLA-R-CHP IN DLBCL: A META-ANALYSIS INCLUDING RCT AND RWS

EHA Library, Giada Pacitto, 4210342

REAL-WORLD OUTCOMES OF GLOFITAMAB-BASED REGIMENS IN DLBCL PATIENTS WITH EXTRANODAL INVOLVEMENT

EHA Library, Yuhong Ren, 4210343

EARLY SEVERE INFECTIONS AND EARLY MORTALITY IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER COHORT FROM ROMANIA

EHA Library, Cosmin Minciuna, 4210344

GLOFITAMAB-BASED THERAPY IN PRIMARY REFRACTORY OR EARLY RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTER REAL-WORLD STUDY IN CHINA

EHA Library, Xia Zhao, 4210345

PROGNOSTIC VALUE OF SERIAL CBC-DERIVED INDICES FROM LEUKAPHERESIS TO DAY 30 IN THIRD-LINE AXICABTAGENE CILOLEUCEL FOR DLBCL

EHA Library, Chokri Ben Lamine, 4210346

IMMUNOHISTOCHEMICAL PRACTICE IN THE DIAGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA IN AUSTRALIA

EHA Library, Vibooshini Ganeshalingam, 4210347

CLINICAL FEATURES AND OUTCOMES OF PEDIATRIC DLBCL: A SINGLE-CENTER EXPERIENCE

EHA Library, Maha Charfi, 4210348

DIAGNOSTIC YIELD OF ENDOSCOPIC BIOPSIES AND CORRELATION BETWEEN ENDOSCOPIC FEATURES AND HISTOLOGICAL SUBTYPES IN PRIMARY GASTRIC LYMPHOMAS

EHA Library, Ameni Yahia, 4210349

HIGH STEM CELL MOBILIZATION FAILURE RATE WITH MITOXANTRONE LIPOSOME-CONTAINING SALVAGE CHEMOTHERAPY IN RELAPSED LYMPHOMA

EHA Library, Xia Zhao, 4210350

GLOFITAMAB IN HEAVILY PRETREATED RELAPSED/REFRACTORY B-CELL LYMPHOMA: A REAL-WORLD SINGLE-CENTER ANALYSIS OF EFFICACY, PROGNOSTIC FACTORS, AND COMBINATION STRATEGIES

EHA Library, Liang Wang, 4210351

OUTPATIENT ADMINISTRATION OF R-ICE IN RELAPSED/REFRACTORY B-CELL LYMPHOMA: A REAL-WORLD SINGLE-CENTER STUDY

EHA Library, Francisca Ribeiro Soares, 4210352

TREATMENT OUTCOMES FOR PATIENTS WITH PRIMARY TESTICULAR LYMPHOMA FOLLOWING THE PTL-2022 PROTOCOL

EHA Library, Daria Koroleva, 4210353

REAL‑WORLD EFFECTIVENESS AND SAFETY OF EPCORITAMAB IN RELAPSED/REFRACTORY AGGRESSIVE B‑CELL LYMPHOMAS: A MULTICENTER ITALIAN STUDY

EHA Library, Francesco GAUDIO, 4210354

CLINICOPATHOLOGIC SPECTRUM AND OUTCOMES OF PRIMARY OVARIAN LYMPHOMA: A RETROSPECTIVE CASE SERIES

EHA Library, Ying Shan, 4210355

ATYPICAL EXTRANODAL DIFFUSE LARGE B-CELL LYMPHOMA: MAPPING RARE SITES AND QUANTIFYING DIAGNOSTIC COMPLEXITY IN A REAL-WORLD COHORT

EHA Library, Mihaela-Sabrina Herdea, 4210356

A  ANALYSIS OF FIRST-LINE TREATMENT WITH POLATUZUMAB VEDOTIN-RITUXIMAB-CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE (POLA-R-CHP) FOR PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA.

EHA Library, Hongmei Jing, 4210357

ASSOCIATION OF PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO WITH CLINICAL OUTCOMES IN DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS OF R-CHOP TREATED PATIENTS

EHA Library, Bonnie R K Singh, 4210358

OPTIMIZING MATRIX-BASED THERAPY THROUGH CHEMO-FREE PROD INDUCTION IN UNFIT PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA (CNSL): A REAL-WORLD RETROSPECTIVE STUDY

EHA Library, Fang Bao, 4210359

CLINICAL AND TREATMENT-RELATED PROGNOSTIC FACTORS IN DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER EXPERIENCE

EHA Library, Maha Charfi, 4210360

POOR PERFORMANCE STATUS MAY PRECLUDE THE USE OF RITUXIMAB, METHOTREXATE, PROCARBAZINE, AND VINCRISTINE IN INDUCTION THERAPY OF PRIMARY CNS DLBCL: A SINGLE-CENTER EXPERIENCE

EHA Library, Vojin Vukovic, 4210361

REAL-WORLD EXPERIENCE WITH R-IDA-RAM IN PREDOMINANTLY SECONDARY CNS LYMPHOMA: AN IRISH SINGLE-CENTRE STUDY

EHA Library, Sarah Connor, 4210362

PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IN LATIN AMERICA: REAL-WORLD CLINICOPATHOLOGICAL CHARACTERISTICS AND SURVIVAL OUTCOMES FROM A NATIONAL REFERENCE CENTER

EHA Library, Luis Felipe Rubalcava Lara, 4210363

EFFICACY OF BTKI PLUS IMMUNOCHEMOTHERAPY IN HIGH-RISK DLBCL: A RETROSPECTIVE ANALYSIS

EHA Library, Wenjin Li, 4210364

INITIAL OUTCOMES OF GLOFITAMAB-BASED REGIMENS IN RELAPSED OR REFRACTORY B-CELL LYMPHOMA: A REAL-WORLD ANALYSIS

EHA Library, Lingke Zhang, 4210365

CLINICAL CHARACTERISTICS AND TREATMENT ANALYSIS OF 7 CASES OF INTRAVASCULAR LARGE B-CELL LYMPHOMA

EHA Library, Xiaoli Yuan, 4210366

REAL-WORLD ANALYSIS OF AXICABTAGENE CILOLEUCEL (AXI-CEL) AS FIRST-LINE CONSOLIDATION THERAPY FOR B-CELL LYMPHOMAS WITH HIGH-RISK FACTORS：A SINGLE-CENTER EXPERIENCE

EHA Library, Jieming Zhang, 4210367

REAL-WORLD OUTCOMES OF SECOND-LINE AXICABTAGENE CILOLEUCEL (AXI-CEL) THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA IN A CANADIAN CENTRE

EHA Library, Catherine Sohier-Poirier, 4210368

COMPARATIVE PATIENT-REPORTED OUTCOMES IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH BISPECIFIC ANTIBODIES VERSUS CHEMOTHERAPY: A STRUCTURED REVIEW OF PUBLISHED EVIDENCE

EHA Library, Lin Alokeh, 4210369

A PROSPECTIVE, CONTROLLED STUDY OF ORELABRUTINIB COMBINED WITH POLA-R VERSUS POLA-R-MINICHP IN THE FIRST-LINE TREATMENT OF ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Xing Zhong, 4210370

CLINICAL PRACTICE PATTERNS AND UNMET NEEDS IN DLBCL MANAGEMENT IN EGYPT: RESULTS OF A NATIONWIDE CROSS-SECTIONAL SURVEY

EHA Library, Mohamed Samra, 4210371

REAL-LIFE EXPERIENCE WITH THE POLA-R-CHP REGIMEN IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A RETROSPECTIVE ANALYSIS

EHA Library, Luca Scalise, 4210372

PD-1/CD20 DUAL-TARGET THERAPY IN UNFIT DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD PILOT STUDY

EHA Library, Shaozhen Chen, 4210373

CLINICAL OUTCOMES AND SURVIVAL PREDICTORS IN PRIMARY EXTRANODAL NON-HODGKIN LYMPHOMA: A SINGLE-CENTER EXPERIENCE

EHA Library, Mihailo Smiljanic, 4210374

ZANUBRUTINIB MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: A PROSPECTIVE SINGLE-ARM STUDY

EHA Library, yanli lai, 4210375